Hyderabad: As the health and life sciences summit BioAsia 2025 concluded on Wednesday, IT minister D. Sridhar Babu announced that the event secured investments worth 15,000 crore in just two days.
The valedictory ceremony was presided over by Union coal and mines minister G. Kishan Reddy and featured a virtual address by Union commerce and industry minister Piyush Goyal.
“Hyderabad is at the forefront of the life sciences economy,” said Kishan Reddy, “serving as the vaccine capital of India. It is also a major hub for IT exports, providing about $15 million of IT services. Telangana plays a huge role in India’s pharmaceutical success contributing to 15 per cent of the country’s pharma income and 40 per cent of bulk products,” he said.
“Hyderabad is highly-powered by research institutes focusing on biomedical research. Adding to this, the National Animal Resource Facility for Biomedical Research was set up at Genome Valley last year for animal experimentation in life sciences,” he added. He mentioned that “India means business” and is open to greater collaborations and investments.
Addressing the meeting, Piyush Goyal said: “India is accelerating the adoption of cutting-edge technologies, strengthening its position as the ‘pharmacy of the world’ by supplying affordable generic medicines to over 200 countries. Our focus is now shifting towards high-value biopharmaceuticals and innovation, with initiatives like the Genome India Project.”
“Telangana is reaping the benefits of these transformational reforms. The region has witnessed industrial growth with key projects such as the Kakatiya Mega Textile Park in Warangal, the industrial node in Zahirabad and the establishment of AIIMS Bibinagar. The state has 2,605 km of national highways built since 2014 and four greenfield corridors under the Bharatmala Project. Additionally, the establishment of a National Turmeric Board at Nizamabad will further boost local industries,” he said.
Under the state government’s C4IA initiative, around 3,000 students from underprivileged backgrounds received training in Synthetic Organic Chemistry. Additionally, five startups were selected for investment from a pool of 464 applications, with 82 per cent of them led by women entrepreneurs.
During the event, Sridhar Babu urged Kishan Reddy to support the establishment of a vaccine testing facility at Genome Valley, further strengthening the region’s role in biotech innovation.